Part B Drug Payment Reform: Lower Expenditures Without Signs of Adverse Effects

Part B Drug Payment Reform: Lower Expenditures Without Signs of Adverse Effects

Published: Aug 28, 2009
Publisher: Princeton, NJ: Mathematica Policy Research
Clients
Download
Authors

Jeffrey Ballou

Bonnie Hart

Joshua Parks

John Hall

Research found that physicians were being reimbursed far in excess of what they were paying for Part B drugs and that there was little incentive in the Medicare payment system to contain drug expenditures.

Follow the Evidence

Interested in the most current findings from Mathematica? Subscribe to our bi-weekly newsletter, Evidence & Insights, to stay up to date with the issues that matter to you.

Sign Me Up